The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.
| Image |  |
|---|---|
| Description | scientific article published on 10 June 2016 |
| Author/s |
author: Pablo Bellot Pedro Zapater |
| Publication date | October 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |